Pseudoscience has recently re-emerged in the U.S. While much of it concerns vaccines, an "oldie" is again making the rounds: ...

has a long half-life allowing for once-daily dosing in treatment-naive patients and has less pharmacokinetic variability compared with other HIV INSTIs. For treatment-naive patients, dolutegravir ...

TAKING up the cudgels for cooperatives playing key role in promoting economic growth and livelihood generation, Senator Sherwin T. Gatchalian has filed a resolution seeking an inquiry into a ...

THE national government borrowed a total of P35 billion from the domestic debt market through its twin offering of Treasury bonds (T-bonds) due to overwhelming demand. The Bureau of the Treasury ...

2024 — Researchers have shown unprecedented control of SIV replication and decay of viral reservoirs by combining a stringent model of infection with the interruption of antiretroviral therapy ...

Physicians and their patients report that engagement in an HIV-based community rivals drug effectiveness in the ongoing efforts to curtail an epidemic. Confronting the HIV Epidemic: There's an App ...

Although the risk is very low, this may influence your decision about switching to injectable treatment. Visit the A-Z of antiretroviral medications to find out more about these research studies.

With further research, early identification may lead to earlier intervention. HealthDay News — Machine learning models may be able to identify women with severe subjective cognitive decline (SCD) ...

The advent of new antiretroviral medicines means that the effects of HIV can now be curbed, but only one in twenty infected people have so far benefited. For those living in developing countries, the ...

This cross-sectional study included HIV-1-ART patients who were recruited from the outpatient clinic at Karolinska University Hospital, Stockholm, Sweden, and HIV-1-negative controls. The inclusion ...